Journals Library


Project Published

View Report

  • Latest project information

HTA - 95/13/01

A randomised controlled trial of longer-term clinical outcomes and cost-effectiveness of standard and new antiepileptic drugs (SANAD)

Project title: A randomised controlled trial of longer-term clinical outcomes and cost-effectiveness of standard and new antiepileptic drugs (SANAD)

Call to action: 95/13 New antiepileptic drugs and existing therapies

Research type: Primary Research

Chief investigator: Professor David Chadwick

Lead Author: Professor Anthony MarsonORCID logoorcid.org/0000-0002-6861-8806

Contractor: University of Liverpool

Cost: £1,349,657.00

Co-investigators: Dr Tony Johnson, Professor Ann Jacoby, Professor Cam Donaldson.

Started: September 1998 | Status: Published October 2007

ISRCTN: 38354748

Trial provides evidence that lamotrigine may be a clinical and cost-effective alternative to the existing standard drug treatment, carbamazepine, for epilepsy patients diagnosed as having partial seizures.

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked

Methods

How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.